COMMUNIQUÉS West-GlobeNewswire

Crinetics Pharmaceuticals to Participate in Two Upcoming Investor Conferences in March
05/02/2026
SAN DIEGO, Feb. 05, 2026 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX), today announced that company management will participate in the following two upcoming investor conferences: TD Cowen 46 th [...]
Ultragenyx to Host Conference Call for Fourth Quarter and Full-Year 2025 Financial Results and Corporate Update
05/02/2026
NOVATO, Calif., Feb. 05, 2026 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development and commercialization of novel products for serious rare and ultra- [...]
Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)
05/02/2026
CONSHOHOCKEN, Pa., Feb. 05, 2026 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL), a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated [...]
Vaxcyte to Present at the Guggenheim Emerging Outlook: Biotech Summit
05/02/2026
SAN CARLOS, Calif., Feb. 05, 2026 (GLOBE NEWSWIRE) -- Vaxcyte, Inc. (Nasdaq: PCVX), a clinical-stage vaccine innovation company, today announced that Company management will participate in a fireside chat at the [...]
Amwell® to report fourth quarter and full year 2025 operating results
05/02/2026
BOSTON, Feb. 05, 2026 (GLOBE NEWSWIRE) -- Amwell ® (NYSE: AMWL), a leading provider of a comprehensive SaaS-based software platform for technology-enabled healthcare, will report fourth quarter and full year 2025 [...]
Adaptive Biotechnologies Reports Fourth Quarter and Full Year 2025 Financial Results
05/02/2026
SEATTLE, Feb. 05, 2026 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (“Adaptive Biotechnologies”) (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive [...]
Eledon Pharmaceuticals to Participate in the Guggenheim Emerging Outlook: Biotech Summit 2026
05/02/2026
IRVINE, Calif., Feb. 05, 2026 (GLOBE NEWSWIRE) -- Eledon Pharmaceuticals, Inc. (“Eledon”) (Nasdaq: ELDN) today announced that Steven Perrin, Ph.D., President and Chief Scientific Officer will participate in a fireside [...]
Surrozen to Present at Upcoming Healthcare Investor Conference
05/02/2026
SOUTH SAN FRANCISCO, Calif., Feb. 05, 2026 (GLOBE NEWSWIRE) -- Surrozen, Inc. (“Surrozen” or the “Company”) (Nasdaq: SRZN), a biotechnology company pioneering targeted therapeutics to harness the power of Wnt signaling [...]
BioPorto provides Preliminary Unaudited 2025 Financial Figures, Financial Guidance for 2026 and a Business Update
05/02/2026
February 5, 2026 Announcement no. 1 BioPorto provides Preliminary Unaudited 2025 Financial Figures, Financial Guidance for 2026 and a Business Update COPENHAGEN, DENMARK, February 5, 2026, (GLOBE NEWSWIRE) – BioPorto A/ [...]
Coeptis Receives Shareholder Approval Towards Z Squared Merger
05/02/2026
Shareholder Approval Clears a Key Condition to Close WEXFORD, Pa., Feb. 05, 2026 (GLOBE NEWSWIRE) -- Coeptis Therapeutics Holdings, Inc. (Nasdaq: COEP) (“Coeptis” or the “Company”), a next-gen technology and [...]
Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
05/02/2026
WESTLAKE VILLAGE, Calif., Feb. 05, 2026 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a commercial-stage biopharmaceutical company focused on developing meaningful innovations in immuno-dermatology, [...]
Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons
05/02/2026
Bagsværd, Denmark, 5 February 2026 — This company announcement discloses the data of the transaction(s) made in Novo Nordisk shares by the company’s board members, executives and their associated persons in accordance [...]
Denali Therapeutics Presents Enzyme TransportVehicle™ Progress Across Three Clinical Programs for Treatment of Lysosomal Storage Disorders at 2026 WORLDSymposium™
05/02/2026
Analysis from continued follow-up of Phase 1/2 clinical trial data in Hunter syndrome (MPS II) reinforces potential for tividenofusp alfa (DNL310) to address full disease spectrum Launch readiness established in [...]
Virbac : Declaration of the number of shares and voting rights 01/2026
05/02/2026
DECLARATION OF THE NUMBER OF SHARES AND VOTING RIGHTS Information on the total number of voting rights and of shares representing the share capital (Article 223-16 of the General regulations of the French Financial [...]
Guerbet : 2025 revenue.
05/02/2026
2025 revenue Full-year revenue: €786.4 million, down 3.5% at CER 1 and on a like-for-like basis 2 , largely due to the fall in business in France A decline in Q4 of 5.6% at CER and on a like-for-like basis, linked to [...]
Guerbet : Chiffre d’affaires 2025.
05/02/2026
Chiffre d’affaires 2025 Chiffre d’affaires annuel : 786,4 M€, soit un repli de 3,5% à TCC 1 et périmètre comparable 2 , largement dû à la baisse de l’activité en France Au quatrième trimestre, une baisse de 5,6% à TCC [...]
Lighthouse Autism Center Announces Opening of New Cedar Falls, IA Location
05/02/2026
Premier ABA Provider Expands Services with 50th Location Nationwide CEDAR FALLS, Iowa, Feb. 05, 2026 (GLOBE NEWSWIRE) -- Lighthouse Autism Center, a leading provider of center-based Applied Behavior Analysis (ABA) [...]
Organic & Natural Health Association Honors SENPA’s Debra Short with Champion Award at Conference Shaping Policy, and the Future of Retail
05/02/2026
FT. LAUDERDALE, Fla., Feb. 05, 2026 (GLOBE NEWSWIRE) -- The Organic & Natural Health Association ’s 11th annual conference, “The United States of Health: Building Bridges to Opportunity,” concluded Jan. 22 with a [...]
Cross Medical Group Announces New Villanova Office Location
05/02/2026
Move Reflects the Philadelphia Area Practice’s Ongoing Commitment to Patient Care VILLANOVA, Pa., Feb. 05, 2026 (GLOBE NEWSWIRE) -- Cross Medical Group, a cosmetic surgery practice specializing in procedures for the [...]

Pages